Insider trades › Eli Lilly › David Ricks

David Ricks: Eli Lilly stock transactions

David Ricks (President, Chair, and CEO, Director at Eli Lilly) reported 1 transaction in LLY stock on SEC Form 4 over the last 120 days. Name as filed with the SEC: Ricks David A.

$0open-market sales (0 shares)
$0open-market purchases (0 shares)
2026-11-03most recent transaction

Transactions

Date Transaction Shares Price Value Filing
Nov 3, 2026 Gift 23,538 — — Form 4 ↗

Source: SEC EDGAR Form 4 filings; each row links to the filing. Sales marked "10b5-1 plan" were reported as made under a pre-arranged trading plan. Insider trades are reported facts, not recommendations. Not investment advice.